MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
7.11
-0.48
-6.32%
After Hours: 7.10 -0.01 -0.14% 19:58 12/31 EST
OPEN
7.58
PREV CLOSE
7.59
HIGH
7.60
LOW
7.04
VOLUME
78.12K
TURNOVER
--
52 WEEK HIGH
98.20
52 WEEK LOW
6.00
MARKET CAP
13.39M
P/E (TTM)
-0.1334
1D
5D
1M
3M
1Y
5Y
1D
BriaCell Subsidiary BriaPro Files Interim Financial Results
TipRanks · 12/29/2025 21:32
Weekly Report: what happened at BCTX last week (1222-1226)?
Weekly Report · 12/29/2025 09:07
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 12/23/2025 17:05
Weekly Report: what happened at BCTX last week (1215-1219)?
Weekly Report · 12/22/2025 09:07
BriaCell’s Phase 3 Breast Cancer Trial Named a 2026 ‘Clinical Trial to Watch’ by Nature Medicine
TipRanks · 12/18/2025 13:27
BriaCell Therapeutics Publishes Phase 3 Bria-IMT Clinical Study In Metastatic Breast Cancer
Benzinga · 12/18/2025 12:34
“ELEVEN CLINICAL TRIALS THAT WILL SHAPE MEDICINE IN 2026” – BRIACELL PHASE 3 TRIAL FEATURED IN NATURE MEDICINE
Reuters · 12/18/2025 12:30
Weekly Report: what happened at BCTX last week (1208-1212)?
Weekly Report · 12/15/2025 09:08
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.